Weighted Average Number of Shares Outstanding, Basic of RIGEL PHARMACEUTICALS INC from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q2 2010 to Q3 2025.
  • Rigel Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 18M shares, a 2.49% increase year-over-year.
  • Rigel Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 17.6M shares, a 1.02% increase from 2023.
  • Rigel Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 17.4M shares, a 2.07% increase from 2022.
  • Rigel Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 17M shares, a 90% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

RIGEL PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 18M +438K +2.49% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-04
Q2 2025 17.9M +336K +1.92% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 17.8M +288K +1.64% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 17.6M +178K +1.02% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-04
Q3 2024 17.6M +164K +0.94% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-04
Q2 2024 17.5M +193K +1.11% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 17.5M -156M -89.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 17.4M +352K +2.07% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-04
Q3 2023 17.4M -155M -89.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 17.4M -155M -89.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 174M +1.79M +1.04% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 17M -153M -90% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-04
Q3 2022 173M +1.95M +1.14% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 172M +1.96M +1.15% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 172M +1.97M +1.16% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 170M +1.45M +0.86% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 171M +1.95M +1.16% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 170M +1.62M +0.96% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 170M +1.33M +0.79% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 169M +1.42M +0.85% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-02
Q3 2020 169M +1.32M +0.79% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 169M +1.38M +0.83% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 168M +1.3M +0.78% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 168M +939K +0.56% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 168M +1.15M +0.69% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-02
Q2 2019 167M +5.61M +3.48% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-02
Q1 2019 167M +20.1M +13.6% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-02
Q4 2018 167M +22.4M +15.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 166M +41.8M +33.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 162M +39.1M +31.9% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 147M +33.5M +29.5% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 144M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 125M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 123M Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 114M Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2012 75M +11.6M +18.4% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-03
Q3 2012 71.6M +410K +0.58% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-06
Q2 2012 71.5M +13.2M +22.6% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-07
Q1 2012 71.4M +19.1M +36.6% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-01
Q4 2011 63.3M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-04
Q3 2011 71.2M +19.1M +36.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 58.3M +6.3M +12.1% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 52.3M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-01
Q3 2010 52.1M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-01
Q2 2010 52M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-02

RIGEL PHARMACEUTICALS INC Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 17.6M +178K +1.02% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-04
2023 17.4M +352K +2.07% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-04
2022 17M -153M -90% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-04
2021 170M +1.74M +1.03% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 169M +1.35M +0.81% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-07
2019 167M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2014 87.7M +374K +0.43% Jan 1, 2014 Dec 31, 2014 10-K 2015-03-03
2013 87.3M +12.3M +16.4% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-03
2012 75M +11.6M +18.4% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-03
2011 63.3M +11.3M +21.7% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-04
2010 52.1M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.